| Literature DB >> 29094765 |
Miriam Gjerdevik1,2, Øystein A Haaland1, Julia Romanowska1,3, Rolv T Lie1,4, Astanand Jugessur1,2,5, Håkon K Gjessing1,5.
Abstract
With case-parent triad data, one can frequently deduce parent of origin of the child's alleles. This allows a parent-of-origin (PoO) effect to be estimated as the ratio of relative risks associated with the alleles inherited from the mother and the father, respectively. A possible cause of PoO effects is DNA methylation, leading to genomic imprinting. Because environmental exposures may influence methylation patterns, gene-environment interaction studies should be extended to allow for interactions between PoO effects and environmental exposures (i.e., PoOxE). One should thus search for loci where the environmental exposure modifies the PoO effect. We have developed an extensive framework to analyze PoOxE effects in genome-wide association studies (GWAS), based on complete or incomplete case-parent triads with or without independent control triads. The interaction approach is based on analyzing triads in each exposure stratum using maximum likelihood estimation in a log-linear model. Interactions are then tested applying a Wald-based posttest of parameters across strata. Our framework includes a complete setup for power calculations. We have implemented the models in the R software package Haplin. To illustrate our PoOxE test, we applied the new methodology to top hits from our previous GWAS, assessing whether smoking during the periconceptional period modifies PoO effects on cleft palate only.Entities:
Keywords: case-parent triad; gene-environment interaction; hybrid design; imprinting; parent-of-origin; power and sample size calculation; trios
Mesh:
Year: 2017 PMID: 29094765 PMCID: PMC5813215 DOI: 10.1111/ahg.12224
Source DB: PubMed Journal: Ann Hum Genet ISSN: 0003-4800 Impact factor: 1.670
PoO, GxE and PoOxE effects for cleft palate‐only example SNPs
|
| ||||
| Test effect | Stratum |
|
|
|
| PoO effects |
| 1.79 | 0.52 | 3.42 (1.86, 6.15) |
|
| 1.79 | 0.52 | 3.42 (1.86, 6.15) | |
|
| 1 (–) | 1 (–) | 1 (–) | |
| GxE effects |
| 1.22 | 1.22 | 1 (–) |
|
| 1.06 | 1.06 | 1 (–) | |
|
| 1.15 (0.51, 2.61) | 1.15 (0.51, 2.61) | 1 (–) | |
| PoOxE effects |
| 1.88 | 0.66 | 2.83 (0.90, 8.63) |
|
| 1.76 | 0.48 | 3.68 (1.80, 7.37) | |
|
| 1.07 (0.43, 2.69) | 1.40 (0.40, 4.83) | 0.77 (0.20, 2.91) | |
|
| ||||
| Test effect | Stratum |
|
|
|
| PoO effects |
| 0.95 | 1.07 | 0.89 (0.67, 1.17) |
|
| 0.95 | 1.07 | 0.89 (0.67, 1.17) | |
|
| 1 (–) | 1 (–) | 1 (–) | |
| GxE effects |
| 0.48 | 0.48 | 1 (–) |
|
| 1.15 | 1.15 | 1 (–) | |
|
| 0.42 (0.26, 0.68) | 0.42 (0.26, 0.68) | 1 (–) | |
| PoOxE effects |
| 0.44 | 0.52 | 0.86 (0.39, 1.87) |
|
| 1.09 | 1.22 | 0.89 (0.66, 1.20) | |
|
| 0.41 (0.21, 0.79) | 0.42 (0.23, 0.80) | 0.96 (0.41, 2.24) | |
|
| ||||
| Test effect | Stratum |
|
|
|
| PoO effects |
| 1.42 | 1.06 | 1.34 (0.90, 1.97) |
|
| 1.42 | 1.06 | 1.34 (0.90, 1.97) | |
|
| 1 (–) | 1 (–) | 1 (–) | |
| GxE effects |
| 1.16 | 1.16 | 1 (–) |
|
| 1.25 | 1.25 | 1 (–) | |
|
| 0.93 (0.54, 1.60) | 0.93 (0.54, 1.60) | 1 (–) | |
| PoOxE effects |
| 0.53 | 2.57 | 0.21 (0.09, 0.46) |
|
| 1.88 | 0.85 | 2.22 (1.41, 3.43) | |
|
| 0.28 (0.13, 0.58) | 3.03 (1.45, 6.35) | 0.09 (0.04, 0.24) | |
*PoO effects were estimated without stratifying on exposure. The rows corresponding to environmental strata are therefore equal by assumption.
**GxE effects were estimated without stratifying on parental origin. The columns related to and are therefore equal by assumption.
‐ The estimates are relative to the most frequent allele
‐ and are the relative risks depending on parental origin
‐ and are the relative risks depending on exposure status (nonsmokers or smokers)
1Overall allele frequencies: A 0.88; T 0.12; Europeans only
2Overall allele frequencies: C 0.57; G 0.43; Whole sample
3Overall allele frequencies: G 0.52; C 0.48; Europeans only
Figure 1Single‐SNP power analysis for the PoOxE test for increasing relative risk ratios (increasing values of ; ) at the 0.05 nominal significance level. Equally sized exposure groups are assumed. Left panel: Increasing number of case–parent triads, and ; Middle panel: Increasing MAFs, and a total of 1500 case–parent triads; Right panel: Power comparison of the PoOxE, GxE (increasing values of ; ), PoO (increasing values of ; ), and fetal effect (increasing values of RR) tests, , and a total of 1500 case–parent triads [Color figure can be viewed at wileyonlinelibrary.com]
Figure 2GWAS power analysis for the PoOxE test for increasing relative risk ratios (increasing values of ; ) and increasing number of case‐parent triads, assuming equally sized exposure groups and . Left panel: Nominal significance level 10−4; right panel: Nominal significance level [Color figure can be viewed at wileyonlinelibrary.com]
Figure 3Simulated P‐values under the null hypothesis of no PoOxE effects based on 100,000 replications of data sets. The cumulative density plots compare the attained significance level with an expected uniform distribution under the null hypothesis (diagonal sloping line). A total of 1000 case–parent triads were divided into two exposure strata, and a MAF of 0.2 was assigned throughout. The distribution of case‐parent triads in each stratum was as follows: 100–900 (dark grey line) and 300–700 (light grey line). If no bias is present, the observed significance levels should equal the nominal level of 0.05 (black dashed lines). The dark and light grey dashed horizontal lines show the attained significance levels corresponding to the simulated scenarios
PoOxE effects for cleft palate–only example haplotypes
| rs2964447‐rs2964137‐rs6868526, | ||||
|---|---|---|---|---|
| Haplotype | Stratum |
|
|
|
| T‐G‐C |
| 1.99 | 0.49 | 4.04 (1.75, 9.25) |
|
| 0.52 | 1.04 | 0.50 (0.31, 0.82) | |
|
| 3.79 (1.74, 8.22) | 0.47 (0.21, 1.05) | 7.98 (3.07, 20.77) | |
| T‐G‐G |
| 1.30 | 0.24 | 5.35 (1.51, 18.19) |
|
| 0.68 | 1.30 | 0.52 (0.29, 0.96) | |
|
| 1.89 (0.70, 5.07) | 0.19 (0.06, 0.62) | 10.13 (2.55, 40.19) | |
‐Reference haplotype: A‐C‐C
‐Overall haplotype frequencies: A‐C‐C 0.48; T‐G‐C 0.36; T‐G‐G 0.16; Europeans only
‐ and are the relative risks depending on parental origin.
‐ and are the relative risks depending on exposure status (nonsmokers or smokers)